Immunostaining experiments performed on lung sections confirmed that ADAM15 staining was increased in lung macrophages in COPD patients versus controls and greater in patients with GOLD stage III-IV versus GOLD stage I-II disease. This evidence concerns the gene ADAM15 and chronic obstructive pulmonary disease.